Latest Breaking News On - Proprietary drug eluting biomatrix platform - Page 1 : comparemela.com

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Surgalign holdings incSecurities exchangeLemaitre vascularMizuho securities united statesElutia incBerkeley biologicsCompany now focused on proprietary drugGroup ltdKilpatrick townsend stocktonExchange commissionNow focusedProprietary drug eluting biomatrix platformChief executive officerKilpatrick townsendSecurities actSecurities exchange act

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Berkeley biologicsDrug administrationLemaitre vascularSecurities exchangeCompany orthobiologicsGroup ltdElutia incExchange commissionMizuho securities united statesSurgalign holdings incTransaction reflects increasing strategic focusProprietary drug eluting biomatrix platformBrandy millsChief executive officerSecurities actSecurities exchange act